Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Expression and biochemical characterization of the Plasmodium falciparum protein kinase A catalytic subunit.

Wurtz N, Pastorino B, Almeras L, Briolant S, Villard C, Parzy D.

Parasitol Res. 2009 Jun;104(6):1299-305. doi: 10.1007/s00436-008-1327-3. Epub 2009 Jan 22.

PMID:
19159956
2.

Characterization of an A-kinase anchoring protein-like suggests an alternative way of PKA anchoring in Plasmodium falciparum.

Bandje K, Naissant B, Bigey P, Lohezic M, Vayssières M, Blaud M, Kermasson L, Lopez-Rubio JJ, Langsley G, Lavazec C, Deloron P, Merckx A.

Malar J. 2016 Apr 29;15:248. doi: 10.1186/s12936-016-1275-9.

3.

The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes.

Syin C, Parzy D, Traincard F, Boccaccio I, Joshi MB, Lin DT, Yang XM, Assemat K, Doerig C, Langsley G.

Eur J Biochem. 2001 Sep;268(18):4842-9.

4.

Phenotypic and transcriptomic analyses of Plasmodium falciparum protein kinase A catalytic subunit inhibition.

Wurtz N, Desplans J, Parzy D.

Parasitol Res. 2009 Nov;105(6):1691-9. doi: 10.1007/s00436-009-1615-6. Epub 2009 Sep 25.

PMID:
19779742
5.

cAMP-dependent protein kinase from Plasmodium falciparum: an update.

Wurtz N, Chapus C, Desplans J, Parzy D.

Parasitology. 2011 Jan;138(1):1-25. doi: 10.1017/S003118201000096X. Epub 2010 Jul 21. Review.

PMID:
20663247
6.

Susceptibility of Plasmodium falciparum cyclic AMP-dependent protein kinase and its mammalian homologue to the inhibitors.

Sudo A, Kato K, Kobayashi K, Tohya Y, Akashi H.

Mol Biochem Parasitol. 2008 Aug;160(2):138-42. doi: 10.1016/j.molbiopara.2008.03.011. Epub 2008 Apr 16.

PMID:
18501980
7.

Isolation and characterisation of a cAMP-dependent protein kinase catalytic subunit gene from Plasmodium falciparum.

Li J, Cox LS.

Mol Biochem Parasitol. 2000 Jul;109(2):157-63. No abstract available.

PMID:
10960174
8.

Molecular characterization of Plasmodium falciparum uracil-DNA glycosylase and its potential as a new anti-malarial drug target.

Suksangpleng T, Leartsakulpanich U, Moonsom S, Siribal S, Boonyuen U, Wright GE, Chavalitshewinkoon-Petmitr P.

Malar J. 2014 Apr 17;13:149. doi: 10.1186/1475-2875-13-149.

9.

PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum.

Dorin D, Semblat JP, Poullet P, Alano P, Goldring JP, Whittle C, Patterson S, Chakrabarti D, Doerig C.

Mol Microbiol. 2005 Jan;55(1):184-96.

10.

Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy.

Reungprapavut S, Krungkrai SR, Krungkrai J.

J Enzyme Inhib Med Chem. 2004 Jun;19(3):249-56.

PMID:
15499996
11.

Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile.

Krungkrai SR, Aoki S, Palacpac NM, Sato D, Mitamura T, Krungkrai J, Horii T.

Mol Biochem Parasitol. 2004 Apr;134(2):245-55.

PMID:
15003844
12.

Disrupting the Allosteric Interaction between the Plasmodium falciparum cAMP-dependent Kinase and Its Regulatory Subunit.

Littler DR, Bullen HE, Harvey KL, Beddoe T, Crabb BS, Rossjohn J, Gilson PR.

J Biol Chem. 2016 Dec 2;291(49):25375-25386. Epub 2016 Oct 13.

13.
14.

Plasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductance.

Merckx A, Nivez MP, Bouyer G, Alano P, Langsley G, Deitsch K, Thomas S, Doerig C, Egée S.

PLoS Pathog. 2008 Feb 8;4(2):e19. doi: 10.1371/journal.ppat.0040019.

15.

Antimalarial activity of novel 4-cyano-3-methylisoquinoline inhibitors against Plasmodium falciparum: design, synthesis and biological evaluation.

Buskes MJ, Harvey KL, Richards BJ, Kalhor R, Christoff RM, Gardhi CK, Littler DR, Cope ED, Prinz B, Weiss GE, O'Brien NJ, Crabb BS, Deady LW, Gilson PR, Abbott BM.

Org Biomol Chem. 2016 May 18;14(20):4617-39. doi: 10.1039/c5ob02517f.

PMID:
27105169
16.

Biochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase I.

Kümpornsin K, Kotanan N, Chobson P, Kochakarn T, Jirawatcharadech P, Jaru-ampornpan P, Yuthavong Y, Chookajorn T.

Malar J. 2014 Apr 19;13:150. doi: 10.1186/1475-2875-13-150.

17.

Exploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic target.

Haste NM, Talabani H, Doo A, Merckx A, Langsley G, Taylor SS.

Microbes Infect. 2012 Aug;14(10):838-50. doi: 10.1016/j.micinf.2012.05.004. Epub 2012 May 22. Review.

18.

High-resolution crystal structure of cAMP-dependent protein kinase from Cricetulus griseus.

Kudlinzki D, Linhard VL, Saxena K, Sreeramulu S, Gande S, Schieborr U, Dreyer M, Schwalbe H.

Acta Crystallogr F Struct Biol Commun. 2015 Aug;71(Pt 8):1088-93. doi: 10.1107/S2053230X1501242X. Epub 2015 Jul 29.

19.

Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum Biochemical properties and possible involvement in MAPK regulation.

Dorin D, Le Roch K, Sallicandro P, Alano P, Parzy D, Poullet P, Meijer L, Doerig C.

Eur J Biochem. 2001 May;268(9):2600-8.

20.

Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.

Diaz CA, Allocco J, Powles MA, Yeung L, Donald RG, Anderson JW, Liberator PA.

Mol Biochem Parasitol. 2006 Mar;146(1):78-88. Epub 2005 Nov 17.

PMID:
16325279

Supplemental Content

Support Center